Osr Holdings, Inc. (OSRHW) — SEC Filings
Osr Holdings, Inc. (OSRHW) — 50 SEC filings. Latest: 8-K (Nov 25, 2025). Includes 35 8-K, 6 10-Q, 3 DEF 14A.
View Osr Holdings, Inc. on SEC EDGAR
Overview
Osr Holdings, Inc. (OSRHW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Nov 25, 2025: OSR Holdings, Inc. filed an 8-K on November 25, 2025, reporting events as of November 21, 2025. The filing indicates a Regulation FD Disclosure and Other Events, along with Financial Statements and Exhibits. The company, formerly known as Bellevue Life Sciences Acquisition Corp., is incorporated in
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 6 bearish, 43 neutral, 1 mixed. The dominant filing sentiment for Osr Holdings, Inc. is neutral.
Filing Type Overview
Osr Holdings, Inc. (OSRHW) has filed 35 8-K, 6 10-Q, 3 DEF 14A, 1 S-1/A, 1 S-1, 2 10-K, 1 SC 13G, 1 SC 13G/A with the SEC between Mar 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of OSRHW's 48 recent filings, 7 were flagged as high-risk, 17 as medium-risk, and 24 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $2.52M |
| Net Income | -$19.81M |
| EPS | N/A |
| Debt-to-Equity | 0.32 |
| Cash Position | $2.18M |
| Operating Margin | N/A |
| Total Assets | $177.29M |
| Total Debt | $43.13M |
Key Executives
- Kuk Hyoun Hwang
- Jun Chul Whang
- Jacqueline Jamin Drohan, Esq.
Industry Context
OSR Holdings, Inc. operates within the global healthcare sector, focusing on innovative therapies and healthcare solutions. Its diverse business segments include oral immunotherapies for cancer, biologics for degenerative diseases, and medical device distribution. The competitive landscape is characterized by rapid technological advancements, significant R&D investment requirements, and stringent regulatory oversight across different healthcare sub-sectors.
Top Tags
material-agreement (9) · warrants (7) · financial-obligation (7) · corporate-action (6) · 8-K (4) · disclosure (4) · 10-Q (4) · corporate-structure (4) · corporate-governance (3) · Medical Devices (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss (9 months ended Sep 30, 2025) | $19.81M | Increased significantly from $8.99 million in the prior year |
| Net Loss (3 months ended Sep 30, 2025) | $3.19M | Slight improvement from $3.36 million in the prior year quarter |
| Net Sales (9 months ended Sep 30, 2025) | $2.52M | Decreased from $2.62 million in the prior year |
| Net Sales (3 months ended Sep 30, 2025) | $627,747 | Decreased from $822,996 in the prior year quarter |
| Cash and Cash Equivalents (Sep 30, 2025) | $2.18M | Increased from $341,543 at December 31, 2024 |
| Net Cash Provided by Financing Activities (9 months ended Sep 30, 2025) | $5.16M | Significant source of cash, up from $862,818 in prior year |
| Selling, General, and Administrative Expenses (9 months ended Sep 30, 2025) | $12.41M | Increased from $10.73 million in the prior year |
| Other Expenses (9 months ended Sep 30, 2025) | $9.33M | Massive increase from $106,069 in the prior year |
| Merger and Acquisition Costs (9 months ended Sep 30, 2025) | $8.70M | New expense item contributing to losses |
| Total Liabilities (Sep 30, 2025) | $43.13M | Increased from $32.03 million at December 31, 2024 |
| SEC File Number | 001-41390 | Identifies the company's filing with the SEC |
| IRS Employer Identification Number | 84-5052822 | Company's tax identification number |
| Number of directors to be elected | 7 | Proposal 1 seeks to elect seven directors to the Board. |
| Maximum common share issuance percentage | 20% | Proposal 4 seeks approval to issue shares exceeding 20% of outstanding common stock. |
| Business Combination Closing Date | February 14, 2025 | Date OSR Holdings, Inc. completed its business combination with OSR Holdings Co., Ltd. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Osr Holdings, Inc. (OSRHW)?
Osr Holdings, Inc. has 50 recent SEC filings from Mar 2024 to Nov 2025, including 35 8-K, 6 10-Q, 3 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of OSRHW filings?
Across 50 filings, the sentiment breakdown is: 6 bearish, 43 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Osr Holdings, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Osr Holdings, Inc. (OSRHW) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Osr Holdings, Inc.?
Key financial highlights from Osr Holdings, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for OSRHW?
The investment thesis for OSRHW includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Osr Holdings, Inc.?
Key executives identified across Osr Holdings, Inc.'s filings include Kuk Hyoun Hwang, Jun Chul Whang, Jacqueline Jamin Drohan, Esq..
What are the main risk factors for Osr Holdings, Inc. stock?
Of OSRHW's 48 assessed filings, 7 were flagged high-risk, 17 medium-risk, and 24 low-risk.
What are recent predictions and forward guidance from Osr Holdings, Inc.?
Forward guidance and predictions for Osr Holdings, Inc. are extracted from SEC filings as they are enriched.